AI
IDXX icon

AXS Investments’s Idexx Laboratories IDXX Stock Holding History

AXS Investments’s Portfolio IDXX Stock Details IDXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$73.2K Sell
139
-16
-10% -$8.97K 0.02% 148
2026
Q1 		$87.1K Sell
155
-48
-24% -$30.8K 0.04% 138
2025
Q4 		$137K Sell
203
-35
-15% -$23.8K 0.05% 138
2025
Q3 		$152K Buy
+238
New +$144K 0.05% 139
2024
Q1 		– Sell
-240
Closed -$133K – 359
2023
Q4 		$133K Sell
240
-28
-10% -$13.1K 0.03% 318
2023
Q3 		$117K Sell
268
-28
-9% -$14K 0.03% 294
2023
Q2 		$149K Buy
296
+8
+3% +$3.83K 0.04% 282
2023
Q1 		$144K Sell
288
-35
-11% -$16.7K 0.05% 243
2022
Q4 		$132K Buy
+323
New +$125K 0.05% 219
2022
Q2 		– Sell
-504
Closed -$276K – 213
2022
Q1 		$276K Sell
504
-975
-66% -$513K 0.11% 120
2021
Q4 		$974K Buy
+1,479
New +$928K 0.23% 77
2021
Q3 		– Sell
-1,309
Closed -$827K – 157
2021
Q2 		$827K Buy
1,309
+276
+27% +$152K 0.25% 86
2021
Q1 		$505K Buy
+1,033
New +$518K 0.18% 104

Other funds holding IDXX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

AXS Investments's IDXX Position: Q2 2026 in Review

AXS Investments reduced its Idexx Laboratories (IDXX) stake by 10% in Q2 2026, selling an estimated $8.97K and leaving 139 shares worth $73.2K. The position accounts for 0.02% of the portfolio, ranked #148.

AXS Investments first reported a position in IDXX in Q1 2021 and has held it in 13 quarters since. The position peaked at $974K in Q4 2021. 1,295 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.

  • AXS Investments held 139 shares of Idexx Laboratories worth $73.2K as of Q2 2026.
  • AXS Investments sold 16 Idexx Laboratories shares in Q2 2026, an estimated $8.97K.
  • Idexx Laboratories made up 0.02% of AXS Investments's portfolio in Q2 2026, its #148 holding.
  • AXS Investments first reported a position in Idexx Laboratories in Q1 2021 and has held it in 13 quarters since.
  • AXS Investments's Idexx Laboratories position peaked at $974K in Q4 2021.
  • 1,295 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.

Based on AXS Investments's 13F filing for Q2 2026, filed 10 Aug 2026.